MetaStat Appoints Richard J. Berman And H. Philip Goodeve To Board Of Directors

MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on understanding and treating systemic metastasis, appointed Richard J. Berman and H. Philip Goodeve to its Board of Directors, effective October 15. Mr. Berman and Mr. Goodeve replace Warren Lau and Dr. Patrick Mooney, both of whom have resigned from the Board. In addition, Johan M. (Thijs) Spoor has resigned as Chairman of the Board while remaining a Board member.

Help employers find you! Check out all the jobs and post your resume.